Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_assertion evidence source_evidence_literature NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_assertion SIO_000772 16564554 NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_assertion wasDerivedFrom lhgdn-20090331 NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_assertion wasGeneratedBy ECO_0000203 NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.